Presentation TCT 2013 Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES? Presenter: Patrick Serruys October 31, 2013
Presentation TCT 2013 REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis Presenter: Ian Meredith October 31, 2013
Presentation TCT 2013 Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case Presenter: Felix Mahfoud October 31, 2013
Presentation TCT 2013 Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI Presenter: Fausto Feres October 31, 2013
Presentation TCT 2013 Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS) Presenter: H. Robert Superko October 31, 2013
Presentation TCT 2013 Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants Presenter: Ori Ben-Yehuda October 31, 2013
Presentation TCT 2013 Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection Presenter: Praveen Chandra October 31, 2013
Presentation TCT 2013 Cardiogenic Shock and Hemodynamic Collapse: From Circulatory Support to Hypothermia Presenter: Michael Mooney October 31, 2013
Presentation TCT 2013 New Interventional Stroke Trials: THERAPY, POSITIVE, IMS4, and Others Presenter: Alexander Khalessi October 31, 2013
Presentation TCT 2013 Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment! Presenter: Augusto Pichard October 31, 2013